Global Rapid Diagnostics Market Outlook and Forecast Report 2020-2025 Featuring Prominent Players - Abbott, Hoffmann-La Roche & Siemens Healthineers

Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Rapid Diagnostics Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Rapid Diagnostics Market Report

The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019-2025.

The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics market. The segment has experienced unprecedented growth after the outbreak of the novel coronavirus. The pandemic, which was initially identified in Wuhan, Hubei Province, China, in December 2019, infected over 35.7 million people, resulting in approximately 1.05 million deaths across the globe till the end of September 2020.

In response to the growing COVID-19 pandemic and the shortage of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or the detection in blood or serum of human antibodies generated in response to the infection.

The global rapid diagnostics market research report includes a detailed segmentation by product, end-users, application, prescription, geography. In 2019, the blood glucose testing segment accounted for a share of over 61% of the rapid diagnostics market. Point of care testing (POCT) for glucose levels is a common procedure performed several times a day in different medical settings worldwide.

POCT glucose devices deliver rapid and relatively precise glucose measurements performed on the blood at patients' bedsides, thereby offering quick results. New technology is constantly being introduced. Implantable sensor devices for continuous glucose monitoring that last three to seven days have been approved by the FDA and allow for strict glycemic controls with less discomfort for the patient.

Insights by Vendors

The global rapid disease diagnostics market is highly dynamic with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents for diagnosing infectious and other diseases. The market is consolidated with global players accounting for dominant shares.

Abbott, BD, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players that account for significant shares in the rapid diagnostics market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Abbott, F. Hoffmann-La Roche, Danaher, Quidel, Luminex, and BD are continuously focusing on product development and offering new diagnostics technology to increase their market presence.

Prominent Vendors

• Abbott

• Hoffmann-La Roche

• Siemens Healthineers

Other Prominent Vendors

• Abaxis

• Abingdon Health

• ACON Laboratories

• AgaMatrix

• Arbor Vita

• Assure Tech

• Autobio

• Beijing Wantai Biopharma

• BioMedomics

• Biomerica

• bioMerieux

• Biopanda Reagents

• Chembio Diagnostic Systems

• Cellex

• Clinical Reference Laboratory

• CTK Biotech

• EKF Diagnostics

• Exact Sciences

• Hangzhou AllTest Biotech

• Hangzhou Biotest Biotech

• Healgen Scientific

• Instrumentation Laboratory

• Megna Health

• Meridian Bioscience

• MP Biomedicals

• NOWDiagnostics

• Salofa Oy

• Sekisui Diagnostics

• SEASUN BIOMATERIALS

• Sinocare

• SureScreen Diagnostics

• Sysmex

• Swiss Precision Diagnostics

• Thermo Fisher Scientific

• Trinity Biotech

• Xiamen Biotime Biotechnology

• Zhejiang Orient Gene Biotech

Upcoming Companies

• Ascensia Diabetes Care Holdings

• LifeScan

• BD

• Quidel

• Danaher

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segments

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview

8 Market Opportunities & Trends
8.1 Increase In Demand For Rapid Tests Due To Covid-19
8.2 Growing Demand For Rapid Molecular Diagnostic Tests
8.3 New Rapid Diagnostics' Approvals/Launches

9 Market Growth Enablers
9.1 Increase In Prevalence/Incidence Of Several Acute And Chronic Diseases
9.2 Preference For Early Diagnosis & Disease Prevention
9.3 Focus on Innovative Rapid Diagnostic Platforms

10 Market Restraints
10.1 Stringent Regulations Coupled With Product Recalls
10.2 Limitations And Data Accuracy Challenges With Rapid Diagnostics

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.4 Instruments/Analyzers

13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Blood Glucose Testing
13.4 Rapid Cardiometabolic Testing
13.5 Rapid Infectious Disease Testing
13.6 Rapid Blood Coagulation Testing
13.7 Rapid Hematology Testing
13.8 Rapid Cancer Testing
13.9 Rapid Drugs Of Abuse Testing
13.10 Pregnancy And Fertility/Ovulation Testing

14 Prescription
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Professional POC Diagnostics
14.4 AT-HOME/OTC-BASED Rapid Diagnostics

15 End-Users
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals And Clinics
15.4 Laboratories
15.5 Home Care
15.6 Others

16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/aueui7

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900